Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
NASDAQ:GH
Holding GH?
Track your performance easily
GH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$15.81 - $37.04
Previous Close$25.08
Volume2.60M
Average Volume (3M)2.20M
Market Cap
$3.09B
Enterprise Value$4.40B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.31B
Price to Earnings (P/E)―
Beta1.89
Next Earnings
Oct 31, 2024EPS Estimate
-$0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.09
Shares Outstanding123,022,076
10 Day Avg. Volume2,818,596
30 Day Avg. Volume2,203,516
Standard Deviation0.17
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-2508.00
Price to Sales (P/S)4.79
Price to Cash Flow (P/CF)-8.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.83
Enterprise Value/Gross Profit13.06
Enterprise Value/Ebitda-7.91
Forecast
1Y Price Target
$42.80Price Target Upside70.65% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
Guardant Health News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceGuardant delivered a strong 9% revenue beat, surpassing market expectations and raising the 2024 guidance significantly.
Market OpportunityThe overall market opportunity for MRD testing is underpenetrated, with significant growth potential in the low single-digit percentage range.
Product EnhancementsPlans to enhance Shield version 2 and add new cancers to the label can drive future growth and market adoption.
Bears Say
Financial PerformanceQ2'24 Adj. EBITDA of -$62M missed analyst expectations of -$48M.
Market AcceptanceExperts doubt the accuracy of imaging-based approaches.
Product EffectivenessAdvanced precancerous lesion sensitivity was relatively low at 31.2%.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GH FAQ
What was Guardant Health’s price range in the past 12 months?
Guardant Health lowest stock price was $15.81 and its highest was $37.04 in the past 12 months.
What is Guardant Health’s market cap?
Currently, no data Available
When is Guardant Health’s upcoming earnings report date?
Guardant Health’s upcoming earnings report date is Oct 31, 2024 which is in 42 days.
How were Guardant Health’s earnings last quarter?
Guardant Health released its earnings results on Aug 07, 2024. The company reported -$0.84 earnings per share for the quarter, missing the consensus estimate of -$0.754 by -$0.086.
Is Guardant Health overvalued?
According to Wall Street analysts Guardant Health’s price is currently Undervalued.
Does Guardant Health pay dividends?
Guardant Health does not currently pay dividends.
What is Guardant Health’s EPS estimate?
Guardant Health’s EPS estimate is -$0.75.
How many shares outstanding does Guardant Health have?
Guardant Health has 123,022,080 shares outstanding.
What happened to Guardant Health’s price movement after its last earnings report?
Guardant Health reported an EPS of -$0.84 in its last earnings report, missing expectations of -$0.754. Following the earnings report the stock price went down -10.866%.
Which hedge fund is a major shareholder of Guardant Health?
Among the largest hedge funds holding Guardant Health’s share is ARK Investment Management LLC. It holds Guardant Health’s shares valued at 13M.
---
Guardant Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$42.80 (70.65% Upside)
$42.80 (70.65% Upside)
Blogger Sentiment
Bullish
GH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 726.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 0.1%
Last 30 Days ▲ 0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.81%
12-Months-Change
Fundamentals
Return on Equity
-337.16%
Trailing 12-Months
Asset Growth
-12.54%
Trailing 12-Months
Company Description
Guardant Health
Guardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.
---
GH Company Deck
---
GH Earnings Call
Q2 2024
0:00 / 0:00
---
GH Revenue Breakdown
91.19% Precision oncology testing
8.81% Development services and other
---
GH Stock 12 Month Forecast
Average Price Target
$42.80
▲(70.65% Upside)
Technical Analysis
Best Analysts Covering GH
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
+12.24%
assigned a buy rating last month
Copying David Westenberg's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of +12.24% per trade.
---